Study of Lenalidomide (Revlimid) in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL) Patients

NCT01036399 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
9
Enrollment
OTHER
Sponsor class

Stopped The EC withdrawn the approval becuase of possible conflicts of interests between our Institute and Supporter (Celgene)

Conditions

Interventions

Sponsor

University of Bologna